REBIF for Multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 989 adverse event reports in the FDA FAERS database where REBIF was used for Multiple sclerosis.
Most Reported Side Effects for REBIF
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Multiple sclerosis relapse | 158 | 9.0% | 3 | 99 |
| Injection site erythema | 137 | 7.8% | 1 | 26 |
| Influenza like illness | 128 | 7.3% | 2 | 23 |
| Fatigue | 123 | 7.0% | 1 | 45 |
| Injection site pain | 105 | 6.0% | 1 | 22 |
| Headache | 96 | 5.5% | 2 | 26 |
| Injection site bruising | 74 | 4.2% | 0 | 16 |
| Pyrexia | 74 | 4.2% | 5 | 33 |
| Fall | 73 | 4.2% | 2 | 36 |
| Pneumonia | 69 | 4.0% | 12 | 42 |
| Urinary tract infection | 69 | 4.0% | 8 | 46 |
| Depression | 65 | 3.7% | 3 | 22 |
| Pain | 63 | 3.6% | 0 | 23 |
| Hypertension | 61 | 3.5% | 1 | 28 |
| Malaise | 61 | 3.5% | 2 | 30 |
Other Indications for REBIF
Product used for unknown indication (516)
Relapsing-remitting multiple sclerosis (207)
Secondary progressive multiple sclerosis (16)
Other Drugs Used for Multiple sclerosis
DIMETHYL (78,567)
NATALIZUMAB (56,733)
INTERFERON BETA-1A (56,475)
FINGOLIMOD (43,123)
TERIFLUNOMIDE (29,963)
DALFAMPRIDINE (28,787)
GLATIRAMER (27,144)
OCRELIZUMAB (15,501)
OFATUMUMAB (11,816)
PEGINTERFERON BETA-1A (11,105)